
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gβ 4 CRISPR/Cas9 KO Plasmid (h) | sc-400820 | 20 µg | $397.00 | |||
Gβ 4 HDR Plasmid (h) | sc-400820-HDR | 20 µg | $445.00 |
GNB4 encodes the human heterotrimeric G protein beta subunit Gβ4, a core component of GPCR signaling that couples activated receptors to downstream effectors. By forming obligate dimers with Gγ subunits, Gβ4 helps regulate Gα cycling and modulates pathways such as adenylyl cyclase/cAMP, phospholipase Cβ/IP3–DAG, ion channel conductance, and MAPK signaling. Through these networks, GNB4 contributes to signal integration controlling neuronal excitability, secretion, chemotaxis, and cytoskeletal dynamics. Altered G protein subunit composition and GPCR pathway dysregulation have been associated with neurological phenotypes and broader signaling defects relevant to mechanistic disease models.
Gβ 4 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the GNB4 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the GNB4 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Gβ 4 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined GNB4 target site.
When co-transfected with Gβ 4 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the GNB4 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.